| Bioactivity | Thalidomide-PEG1-piperazine-2-F-Ph-CHO is an E3 ligase ligand-linker conjugate, used for the synthesis of YD54 (HY-168221)[1]. |
| Formula | C26H25FN4O6 |
| Molar Mass | 508.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sasikumar Kotagiri, et al. Discovery of Novel, Potent and Orally Bioavailable SMARCA2 PROTACs with Synergistic Anti-tumor Activity in Combination with KRAS G12C Inhibitors. bioRxiv. 2024 Aug 26:2024.08.23.608456. |
Thalidomide-PEG1-piperazine-2-F-Ph-CHO
CAS: F: C26H25FN4O6 W: 508.50
Thalidomide-PEG1-piperazine-2-F-Ph-CHO is an E3 ligase ligand-linker conjugate, used for the synthesis of YD54 (HY-16822
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.